| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/27/2001 | US6207710 Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | US6207654 Intravenously administering hydroxyethyl starch or dextran or their mixture and interferon or interleukins for treating human to prevent leakage of macromolecules from capillary endothelial junctions due to side effects of cancer, infection |
| 03/27/2001 | US6207648 Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207644 Peptide analogues containing a 7-membered lactam ring |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207641 Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases |
| 03/27/2001 | US6207640 Treatment of partial growth hormone insensitivity syndrome |
| 03/27/2001 | US6207639 Contacting a neuron with a cell adhesion modulating peptide that comprises a cyclic peptide in which nonadjacent amino acid residues are covalently linked to form a peptide ring comprising sequence his-ala-val within cyclic peptide ring |
| 03/27/2001 | US6207638 For enhancing and extending post meal satiety by stimulating cholecystokinin levels in a calorically efficient manner for reducing weight, comprising protein consisting of casein, whey and soy, glycomacropeptide, long chain fatty acids, fibers |
| 03/27/2001 | US6207456 Nucleic acid delivery vehicle |
| 03/27/2001 | US6207454 Exposing target mammalian cell that expresses stem cell factor receptor to active stem cell factor or analog, then introducing polynucleotide to cell; gene therapy |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207431 Glutamine:fructose-6-phosphate amidotransferase, its production and use |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207416 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207412 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207399 Methods of determining endogenous thrombin potential (ETP) and thrombin substrates for use in said methods |
| 03/27/2001 | US6207398 Lysing red blood cells in a sample of whole blood containing cyclosporin a, contacting the sample with excess of labeled anti-cyclosporin antibody to form a complex, separating unbound antibody, contacting complex with cyclosporins |
| 03/27/2001 | US6207393 Detection of modulators of signal transduction; form mixture containing enzyme inhibitors of serine/threonine kinase, detect reduction in binding of inhibitor |
| 03/27/2001 | US6207390 Incubating target with biotin in mixture, allow biotinylation, incubate heterogenous mix with solid support, incubate with target, monitor preferential binding of avidins |
| 03/27/2001 | US6207389 Methods of controlling T lymphocyte mediated immune responses |
| 03/27/2001 | US6207386 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207200 Administering an antiviral protein to patient infected with human immunodefficiency virus type i |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207160 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 03/27/2001 | US6207159 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207156 Specific antibodies and antibody fragments |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207151 Increasing solubility; mixing phosphate buffer and anionic polymer |
| 03/27/2001 | US6207150 Variants of thymidine kinase, nucleic acids encoding them, and methods of using them |
| 03/27/2001 | US6207149 Starch binding domains (SBDs) for oral care products |
| 03/27/2001 | US6207148 Polypeptide |
| 03/27/2001 | US6207146 Gene expression in mammalian cells |
| 03/27/2001 | US6207145 Therapeutic applications of high dose interferon |
| 03/27/2001 | US6207144 Polypeptides with interleukin-16 activity, process for the preparation and use thereof |
| 03/27/2001 | US6207066 Method for purification of a blood component |
| 03/27/2001 | US6206914 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2166297C Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2073350C Ribonuclease dimers and method of preparing them |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/22/2001 | WO2001020337A1 GENETIC TESTING FOR PERIODONTITIS BASED ON CATHEPSIN c |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020037A2 Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001020001A1 Nadph-oxidase thyroid enzyme, nucleic acid coding for same and applications thereof |
| 03/22/2001 | WO2001019999A1 A GENE ENCODING A NOVEL THREONYL-tRNA SYNTHETASE, ITS USES AND THE PREPARING METHODS |
| 03/22/2001 | WO2001019993A2 Virulence genes of m. marinum and m. tuberculosis |
| 03/22/2001 | WO2001019991A1 Compositions and methods for the treatment of immune related diseases |
| 03/22/2001 | WO2001019990A1 Rip-3-like death-associated kinase |
| 03/22/2001 | WO2001019986A1 Peptide leukotriene receptor |
| 03/22/2001 | WO2001019985A1 Novel receptors and genes encoding the same |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019966A2 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | WO2001019965A1 Methods and compositions for preserving chondrocytes and uses |
| 03/22/2001 | WO2001019964A1 Chondrocyte compositions, preparation and use thereof |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019955A2 Lysosomal targeting pathway enzymes |
| 03/22/2001 | WO2001019871A2 Delivery system for antidandruff agent |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019869A1 Dendritic cell membrane protein cire |
| 03/22/2001 | WO2001019868A1 A novel angiogenesis inhibitor |
| 03/22/2001 | WO2001019867A1 Prion-related protein |
| 03/22/2001 | WO2001019866A1 Dipeptidyl peptidases |
| 03/22/2001 | WO2001019865A1 A novel muskelin and its application and producing method |
| 03/22/2001 | WO2001019864A1 Polynucleotides encoding novel human angiotensin ii-1 receptor proteins and the method of preparation and its use |
| 03/22/2001 | WO2001019863A1 Preparation of highly pure toxin fragments |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019858A2 A family of ubiquitin-like proteins binds the atpase domain of hsp70-like stch |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019854A2 Neurotransmitter transporter |
| 03/22/2001 | WO2001019852A2 Methods of peptide preparation |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019850A2 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | WO2001019849A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh¿2? |
| 03/22/2001 | WO2001019847A1 A binding motif of a receptor |
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019842A1 Subunit optimized fusion proteins |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |